Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Experimental and Clinical Cardiology|August 4, 2009
A molecular mechanism improving the contractile state in human myocardial hypertrophyOliver Ritter, Nico Bottez, Natalie Burkard, et al.Circulation|February 23, 2005
Targeted proteolysis sustains calcineurin activationNatalie Burkard, Jan Becher, Cornelia Heindl, et al.FEBS Letters|October 14, 2025
Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid-derived monolayers compared to HeLa cellsMastura Neyazi, Pilar Samperio Ventayol, Natalie Burkard, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|May 7, 2016
The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and diseaseMichael Meir, Sven Flemming, Natalie Burkard, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2002
AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathwayOliver Ritter, Kai Schuh, Marc Brede, et al.Shock (Augusta, Ga.)|May 25, 2017
Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in SepsisSven Flemming, Natalie Burkard, Michael Meir, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|August 22, 2015
Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitroMichael Meir, Sven Flemming, Natalie Burkard, et al.Scientific Reports|March 18, 2018
Evaluation of a Miniaturized Biologically Vascularized Scaffold in vitro and in vivoSebastian Kress, Johannes Baur, Christoph Otto, et al.Cardiovascular Research|May 7, 2009
Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusionUlrich Hofmann, Natalie Burkard, Carolin Vogt, et al.Tissue Barriers|October 25, 2022
Plakophilin 2 regulates intestinal barrier function by modulating protein kinase C activity in vitroSimon Nagler, Yalda Ghoreishi, Catherine Kollmann, et al.Pageof 3